Company RaySearch Laboratories AB

Equities

RAY B

SE0000135485

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for RaySearch Laboratories AB

EPS Revisions

Annual profits - Rate of surprise

Sector Medical Software & Technology Services

Real-time Estimate Cboe Europe Other stock markets 10:56:10 2024-04-23 am EDT			5-day change	1st Jan Change
117.7 ^SEK	+0.60%		+2.60%	+31.34%

Apr. 11	National Institutes for Quantum Science and Technology Selects RaySearch Laboratories AB for Clinical Use at the QST Hospital	CI
Feb. 23	Transcript : RaySearch Laboratories AB, 2023 Earnings Call, Feb 23, 2024

RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Companyâs products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Companyâs commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

Number of employees: 388

SEK in Million	2021	Weight	2022	Weight	Delta
Licenses 46.0 %	307	47.9 %	388	46.0 %	+26.48%
Support 38.3 %	269	41.8 %	323	38.3 %	+20.33%
Hardware 12.5 %	51	8.0 %	106	12.5 %	+105.38%
Training and Other 3.1 %	15	2.3 %	26	3.1 %	+81.41%

SEK in Million	2021	Weight	2022	Weight	Delta
United States 38.2 %	215	33.5 %	322	38.2 %	+49.65%
Other Countries 23.6 %	140	21.8 %	199	23.6 %	+42.34%
Japan 12.1 %	101	15.7 %	102	12.1 %	+1.33%
France 7.3 %	46	7.1 %	61	7.3 %	+34.18%
United Kingdom 4.7 %	44	6.8 %	39	4.7 %	-10.22%
Germany 4.1 %	32	5.1 %	34	4.1 %	+6.13%
China 3.5 %	16	2.5 %	30	3.5 %	+85.42%
Netherlands 1.6 %	14	2.2 %	13	1.6 %	-6.37%
South Korea 1.5 %	7	1.1 %	13	1.5 %	+71.14%
Belgium 1.5 %	15	2.3 %	12	1.5 %	-16.31%
Austria 1.0 %	6	1.0 %	9	1.0 %	+37.29%
Sweden 1.0 %	5	0.8 %	9	1.0 %	+72.53%

Managers	Title	Age	Since
Johan Löf FOU	Founder	55	99-12-31
Annika Blondeau Henriksson DFI	Director of Finance/CFO	55	23-07-06
Kjell Eriksson CTO	Chief Tech/Sci/R&D Officer	51	00-12-31
Lotta Larsson HRO	Human Resources Officer	-	10-05-31
Petra Jansson LAW	General Counsel	-	17-06-30
David Hedfors LAW	General Counsel	-	01-12-31
Lars Jordeby SAM	Sales & Marketing	59	13-12-31
Henrik Friberger PRN	Corporate Officer/Principal	53	00-12-31
Peter Kemlin SAM	Sales & Marketing	50	11-12-31
Björn Hårdemark PRN	Corporate Officer/Principal	47	99-12-31

Members of the board	Title	Age	Since
Carl Filip Bergendal FOU	Founder	79	99-12-31
Johan Löf FOU	Founder	55	99-12-31
Hans Lennart Rudolf Wigzell CHM	Chairman	86	04-04-30
Britta Wallgren BRD	Director/Board Member	61	18-05-29
Günther Mårder BRD	Director/Board Member	42	22-11-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	7,654,975	0	0	71.84 %
Stock B	1	26,627,798	24,628,684 ( 92.49 %)	0

Name	Equities	%	Valuation
Premier Fund Managers Ltd. 10.17 %	2,706,951	10.17 %	29 M kr
AFA Sjukförsäkringsaktiebolag (Invt Mgmt) 6.990 %	1,861,254	6.990 %	20 M kr
Swedbank Robur Fonder AB 6.760 %	1,800,000	6.760 %	19 M kr
Invesco Advisers, Inc. 5.203 %	1,385,379	5.203 %	15 M kr
Andra AP-fonden 4.585 %	1,220,942	4.585 %	13 M kr
Tanglin Asset Management AB 1.679 %	447,165	1.679 %	5 M kr
Garraway Capital Management LLP 1.393 %	370,866	1.393 %	4 M kr
Metzler Asset Management GmbH 0.9734 %	259,200	0.9734 %	3 M kr
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 0.7886 %	210,000	0.7886 %	2 M kr
Aktia Fondbolag Ab 0.7568 %	201,510	0.7568 %	2 M kr

Name	Equities	%	Valuation
Johan Löf 73.84 %	6,243,084	73.84 %	67 M kr
Sven Anders Brahme 13.60 %	1,150,161	13.60 %	12 M kr
Carl Filip Bergendal 12.08 %	1,021,577	12.08 %	11 M kr

RaySearch Laboratories AB

Eugeniavägen 18

103 65, Stockholm

+46 8 51 05 30 00

http://www.raysearchlabs.com

address RaySearch Laboratories AB(RAY B)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

117 SEK

Average target price

135 SEK

Spread / Average Target

+15.38%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Software & Technology Services

	1st Jan change	Capi.
RAYSEARCH LABORATORIES AB	+29.57%	367M
VEEVA SYSTEMS INC.	+3.40%	32.12B
PRO MEDICUS LIMITED	+11.88%	7B
SECTRA AB	+14.39%	3.64B
EVOLENT HEALTH, INC.	-9.60%	3.4B
OMNICELL, INC.	-25.11%	1.29B
LUNIT INC.	-34.43%	1.12B
SIMULATIONS PLUS, INC.	+0.56%	899M
VERADIGM INC.	-26.79%	827M
B-SOFT CO.,LTD.	-42.14%	808M

Medical Software & Technology Services